Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab vs Alendronate in RA Females with Low Bone Mass
NCT01770106Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Dec 2012
- Primary completion
- Jun 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in osteoporosis, sponsored by The Chinese University of Hong Kong. Started Dec 2012; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01770106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01770106.